1st Quarter - Report
ALPINE GROUP PARTNERS, LLC. for EMERGENT BIOSOLUTIONS
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 H.R 2366/S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEENAN AUSTIN REED New | Chief of Staff, Rep. Donald McEachin; Deputy Chief of Staff, Rep. Frederica S. Wilson |
| COURTNEY JOHNSON | — |
| NEAL PATEL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.